Liu Tian
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Ivarmacitinib for Refractory Behcet's Syndrome (NCT07634848) | Liu Tian | 2026-06-01 |
| Ustekinumab for Intestinal Behçet's Syndrome With Myelodysplastic Syndrome (NCT07582991) | Liu Tian | 2024-03-24 |
| Upadacitinib for Refractory Takayasu Arteritis (NCT07500467) | Liu Tian | 2024-03-19 |
| Upadacitinib for Refractory Behcet's Syndrome (NCT07080346) | Liu Tian | 2024-01-25 |
| Baricitinib for Refractory Takayasu Arteritis (NCT06662721) | Liu Tian | 2023-04-03 |
| Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus (NCT05339217) | Liu Tian | 2023-02-07 |
Track Liu Tian automatically
Every clearance here is in the API, with alerts when new ones post.